60 Minutes With the IAS–USA Volunteer Board: Hot Topics and Emerging Data in HIV Research and Care
Friday, October 7, 2016
1:00 PM (ET), 12:00 PM (CT), 11:00 AM (MT), 10:00 AM (PT)
The IAS–USA volunteer Board of Directors will meet for the annual Board of Directors meeting. Again this year, the Board will conduct a live, hour-long, interactive, roundtable webinar covering current questions and issues in HIV research and care. The annual IAS–USA volunteer Board meeting is crucial to the development of IAS–USA continuing medical education (CME) activities, as new research that is expected to be released is discussed, a comprehensive assessment of gaps in the knowledge or practice is reviewed, and the gaps and needs assessments combined from all IAS–USA CME activities in the previous year are evaluated.
At the conclusion of this webinar, participants will be able to describe current issues in research and care for HIV including:
- Advances in strategies for antiretroviral therapy
- Future strategies for therapy including discussions on long-acting agents, dual therapy, and more
- Important issues in STIs and OI prevention in HIV infection
- Future directions in HIV prevention
- What's up with Cure?
- What's up with eliminating the epidemic?
Who Should Attend
This webinar is an advanced activity designed for physicians who are actively treating patients with HIV infection, involved in HIV research, or experienced in HIV patient care.
This activity is also relevant for other clinicians, including nurse practitioners and other nursing professionals, physician assistants, and pharmacists.
Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.
Registration closes on Thursday, October 6, 2016, 4:00 PM (PT).
Certificates will be available after the completion of the evaluation and claim form.
For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.
Conflicts of Interest
In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Provider # 5-115. This program is approved for 1.5 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.5 hours (0.15 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN # 0761-9999-16-268-L02-P
This activity is funded by the International Antiviral Society–USA (IAS–USA).